A Study of PHST001 in Advanced Solid Tumors
Pheast Therapeutics
Pheast Therapeutics
National Institutes of Health Clinical Center (CC)
Chinese University of Hong Kong
Actuate Therapeutics Inc.
National Cancer Institute (NCI)
Eisai Inc.
Guangdong Provincial People's Hospital
Northwell Health
OHSU Knight Cancer Institute
Children's Oncology Group
City of Hope Medical Center
Shanghai Children's Medical Center
National Research Oncology and Transplantology Center, Kazakhstan
Helix BioPharma Corporation
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University Health Network, Toronto
Dana-Farber Cancer Institute
GI Innovation, Inc.
Teclison Ltd.
Lahey Clinic
University of Birmingham
Damanhour University
Odense University Hospital
Lahey Clinic
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Imperial College London
Damanhour University
Eastern Cooperative Oncology Group
University of Oxford
Zhujiang Hospital
Northwestern University
Moscow Clinical Scientific Center
Imunon
Odense University Hospital
National Cancer Institute (NCI)
Holy Name Medical Center, Inc.
Ruhr University of Bochum
University of Aarhus
Merit Medical Systems, Inc.
Valerio Therapeutics
American College of Radiology Imaging Network
Sixth Affiliated Hospital, Sun Yat-sen University
University of Wisconsin, Madison
Virginia Commonwealth University
Assiut University
International Group of Endovascular Oncology
International Group of Endovascular Oncology
UNC Lineberger Comprehensive Cancer Center